Company Profiles

driven by the PitchBook Platform

Kato Pharmaceuticals

Description

Operator of a pharmaceutical company. The company is focused on development of treatments for ophthalmic disorders.

2011

Founded

PRIVATE

Status

Series A

Latest Deal Type

$3.75M

Latest Deal Amount

$3.75M

Total Amount Raised

1

Investors

Description

Operator of a pharmaceutical company. The company is focused on development of treatments for ophthalmic disorders.

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Discovery Tools (Healthcare)
Pharmaceuticals

Primary Office

1901 Avenue Of The Stars Suite 700 Los Angeles, CA 90067United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Kato Pharmaceuticals's full profile, request a free trial.

    Kato Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Kato Pharmaceuticals Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Kato Pharmaceuticals Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Fjord VenturesVenture CapitalMinority000 0000000 0000
    Fjord Ventures Venture Capital

    Kato Pharmaceuticals Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Terrance McGovernChief Executive Officer
    Terrance McGovern Chief Executive Officer
    Request full access to PitchBook